Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression

Description:

[68Ga]Ga-PentixaFor PET-CT will be performed in patients with Small cell lung cancer (SCLC) to confirm the targeting of CXCR4 by [68Ga]Ga-PentixaFor

Sponsor:

Institut Cancerologie de l'Ouest

Contacts:

Marie LACOMBE, MD

marie.lacombe@ico.unicancer.fr

+33 241352700

Nadia ALLAM, PhD

nadia.allam@ico.unicancer.fr

+33 2 40 67 98 26

Government Study Link:

NCT07007325 - Click here to see study on

ClinicalTrials.gov

[68Ga]Ga-PENTIXAFOR

Isotope(s):

Target(s):

Ligand: Peptides

Chelator: DOTA

Contact XCancer: 402-991-8468